2022 Society for Immunotherapy of Cancer (SITC) Annual Meeting
Advertisement
AgenT-797 is a scalable, off-the-shelf therapy that retains potent cytotoxicity after cryopreservation.
Patients with LBCL received prophylactic anakinra to reduce the risk of cytokine release syndrome following CAR-T.
Penpulimab demonstrated a good safety profile in patients with relapsed/refractory classical Hodgkin lymphoma.